EFX EQUIFAX INC
AI brief AI-written, not reviewed by a person
Latest period figures show cash and equivalents at 192,900,000 USD as of 2026-09-30, with year-end 2025-12-31 cash at 180,800,000 USD; diluted EPS for the 12 months ended 2025-12-31 was 5.32 USD per share, and diluted EPS for the quarter ended 2026-09-30 was 1.79 USD per share. Stockholders' equity at 2026-09-30 stood at 4,472,800,000 USD, while total assets and liabilities as of 2026-09-30 were 11,937,100,000 USD and 7,323,000,000 USD respectively. The latest quarter ended 2026-09-30 yielded operating cash flow of 355,300,000 USD and revenue for the 12 months ended 2025-12-31 was 6,074,500,000 USD.
- Cash and equivalents declined from 192,900,000 USD on 2026-09-30 to 170,100,000 USD on 2026-06-30, then rose to 183,400,000 USD on 2026-03-31, with 180,800,000 USD at 2025-12-31 and 189,000,000 USD at 2025-09-30. [1]
- 12 months to 2025-12-31 diluted EPS was 5.32 USD per share; 12 months to 2024-12-31 diluted EPS was 4.84 USD per share. [1]
- 3 months to 2026-09-30 diluted EPS was 1.79 USD per share; 3 months to 2026-06-30 was 1.54 USD; 3 months to 2026-03-31 was 1.42 USD; 3 months to 2025-09-30 was 1.29 USD; 3 months to 2025-06-30 was 1.53 USD. [1]
- Stockholders' equity at 2026-09-30 was 4,472,800,000 USD; at 2026-06-30 it was 4,380,200,000 USD; at 2026-03-31 it was 4,540,700,000 USD; at 2025-12-31 it was 4,604,300,000 USD; at 2025-09-30 it was 4,938,500,000 USD. [1]
- Long-term debt as of 2026-09-30 was 5,049,000,000 USD; 2026-06-30 was 4,056,800,000 USD; 2026-03-31 was 4,055,600,000 USD; 2025-12-31 was 4,055,300,000 USD; 2025-09-30 was 4,053,800,000 USD. [1]
- Net income for 12 months to 2025-12-31 was 660,300,000 USD; for 12 months to 2024-12-31 was 604,100,000 USD. [1]
- 3 months to 2026-09-30 operating cash flow was 355,300,000 USD; 3 months to 2026-06-30 was 314,200,000 USD; 3 months to 2026-03-31 was 287,700,000 USD; 3 months to 2025-09-30 was 264,300,000 USD; 3 months to 2025-06-30 was 310,800,000 USD. [1]
- Operating cash flow for 12 months to 2025-12-31 was 1,615,700,000 USD; for 2024-12-31 was 1,324,500,000 USD. [1]
- Revenue for 12 months to 2025-12-31 was 6,074,500,000 USD; for 2024-12-31 was 5,681,100,000 USD. [1]
- Revenue for 3 months to 2026-09-30 was 1,692,500,000 USD; 3 months to 2026-06-30 was 1,700,100,000 USD; 3 months to 2026-03-31 was 1,648,900,000 USD; 3 months to 2025-09-30 was 1,544,900,000 USD; 3 months to 2025-06-30 was 1,537,000,000 USD. [1]
- Shares outstanding as of 2026-10-09 were 117,017,174; 2026-07-10: 117,484,896; 2026-04-10: 119,072,409; 2026-01-30: 120,269,998; 2025-10-10: 122,394,037. [1]
- Total assets as of 2026-09-30 were 11,937,100,000 USD; 2026-06-30: 11,981,800,000 USD; 2026-03-31: 11,942,000,000 USD; 2025-12-31: 11,864,200,000 USD; 2025-09-30: 11,831,800,000 USD. [1]
- Total liabilities as of 2026-09-30 were 7,323,000,000 USD; 2026-06-30: 7,461,900,000 USD; 2026-03-31: 7,259,200,000 USD; 2025-12-31: 7,126,000,000 USD; 2025-09-30: 6,756,000,000 USD. [1]
- 10-Q filed 2026-10-20, accession 0000033185-26-000044; indicates filing activity around 2026-10-20. [1]
- 8-K filed 2026-10-20, accession 0000033185-26-000037; indicates filing activity around 2026-10-20. [1]
Written by OpenVibe.AI from the SEC numbers and filings on this page, not reviewed by a person. Informational only; not investment advice. Written from figures and filings up to (gpt-5-nano-2025-08-07).
Observations
| Metric | Value | Observed | Source | Retrieved | Freshness |
|---|---|---|---|---|---|
| Revenue (quarter) (3 months to 2026-09-30) | 1,692,500,000 USD | sec-companyfacts | current | ||
| Revenue (year) (12 months to 2025-12-31) | 6,074,500,000 USD | sec-companyfacts | current | ||
| Net income (quarter) (3 months to 2026-09-30) | 211,700,000 USD | sec-companyfacts | current | ||
| Net income (year) (12 months to 2025-12-31) | 660,300,000 USD | sec-companyfacts | current | ||
| Operating income (quarter) (3 months to 2026-09-30) | 355,300,000 USD | sec-companyfacts | current | ||
| Operating income (year) (12 months to 2025-12-31) | 1,095,200,000 USD | sec-companyfacts | current | ||
| Diluted EPS (quarter) (3 months to 2026-09-30) | 1.79 USD/shares | sec-companyfacts | current | ||
| Diluted EPS (year) (12 months to 2025-12-31) | 5.32 USD/shares | sec-companyfacts | current | ||
| Operating cash flow (quarter) (3 months to 2026-03-31) | 241,900,000 USD | sec-companyfacts | current | ||
| Operating cash flow (year) (12 months to 2025-12-31) | 1,615,700,000 USD | sec-companyfacts | current | ||
| Total assets (at 2026-09-30) | 11,937,100,000 USD | sec-companyfacts | current | ||
| Total liabilities (at 2026-09-30) | 7,323,000,000 USD | sec-companyfacts | current | ||
| Stockholders' equity (at 2026-09-30) | 4,472,800,000 USD | sec-companyfacts | current | ||
| Cash and equivalents (at 2026-09-30) | 192,900,000 USD | sec-companyfacts | current | ||
| Long-term debt (at 2026-09-30) | 5,049,000,000 USD | sec-companyfacts | current | ||
| Shares outstanding (at 2026-10-09) | 117,017,174 shares | sec-companyfacts | current |
Context
No reviewed context has been published for EFX. The observations and documents below are shown as their sources stated them.
Documents
Source freshness
| Source | Freshness | Last successful fetch | Stale after | Sources reports |
|---|---|---|---|---|
| SEC EDGAR: company financial facts (XBRL) sec-companyfacts | current | 10080 min | ok | |
| SEC EDGAR: latest XBRL filings sec-xbrl-filings | current | 45 min | healthy |
Watch this instrument
Sign in to add EFX to a private watchlist or to get an alert when a new document or observation arrives.
Machine-readable: EFX.json (the same data with every timestamp and source).
Information only — not investment advice; no trading here. OpenVibe.Trade holds no money or assets, takes no orders and gives no personal recommendations.